
1. antimicrob agents chemother. 2017 mar 24;61(4). pii: e02048-16. doi:
10.1128/aac.02048-16. print 2017 apr.

use optical imaging technology validation new, rapid,
cost-effective drug screen part tiered vivo screening paradigm for
development drugs treat cutaneous leishmaniasis.

caridha d(1), parriot s(2), hudson th(2), lang t(3), ngundam f(2), leed s(2),
sena j(2), harris m(2), o'neil m(2), sciotti r(2), read l(2), lecoeur h(3),
hickman m(1), grogl m(2).

author information: 
(1)walter reed army institute research, experimental therapeutics branch of
the military malaria research program, silver spring, maryland, usa
diana.caridha2.ctr@mail.mil mark_r_hickman@yahoo.com.
(2)walter reed army institute research, experimental therapeutics branch of
the military malaria research program, silver spring, maryland, usa.
(3)institut pasteur, unité d'immunophysiologie et parasitisme intracellulaire,
département de parasitologie et mycologie, paris, france.

in drug discovery development effort, reduction time lead
optimization cycle critical decrease time license reduce costs. 
in addition, ethical guidelines call ethical use animals to
minimize number animals used decrease suffering. therefore, 
effort develop drugs treat cutaneous leishmaniasis requires multiple tiers 
of vivo testing start higher-throughput efficacy assessments and
progress lower-throughput models clinical relevance. here, we
describe validation high-throughput, first-tier, noninvasive model of
lesion suppression uses vivo optical imaging technology the
initial screening compounds. strong correlation luciferase activity 
and parasite load 18 days postinfection found. correlation 
allows direct assessment effects drug treatment parasite burden.
we demonstrate strong correlation drug efficacy measured 
on day 18 postinfection suppression lesion size day 60
postinfection, allows us reach accurate conclusion drug efficacy
in 18 days. compounds demonstrating significant reduction the
bioluminescence signal compared control animals tested in
lower-throughput, definitive tests lesion cure balb/c mice golden 
syrian hamsters (gsh) using old world new world parasites.

copyright © 2017 caridha et al.

doi: 10.1128/aac.02048-16 
pmcid: pmc5365718
pmid: 28137819  [indexed medline]

